chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: does not feel well after getting the shot; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (does not feel well after getting the shot) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (does not feel well after getting the shot). At the time of the report, MALAISE (does not feel well after getting the shot) outcome was unknown.            No concomitant medications were reported.  No treatment information was reported.   Reporter did not allow further contact
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Poor quality product administered, Product temperature excursion issue
Clinical narrative: The vial went to temperature excursion/ The (BUD) refrigeration date on 27-Jul-2022 and vaccine was administered on 29-Jul-2022; No adverse event; Erroneously vaccinated clients with expired vaccine/ administered with vaccine that underwent temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine/ administered with vaccine that underwent temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (The vial went to temperature excursion/ The (BUD) refrigeration date on 27-Jul-2022 and vaccine was administered on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 55-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 017B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-Jul-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine/ administered with vaccine that underwent temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (The vial went to temperature excursion/ The (BUD) refrigeration date on 27-Jul-2022 and vaccine was administered on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine/ administered with vaccine that underwent temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (The vial went to temperature excursion/ The (BUD) refrigeration date on 27-Jul-2022 and vaccine was administered on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine/ administered with vaccine that underwent temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (The vial went to temperature excursion/ The (BUD) refrigeration date on 27-Jul-2022 and vaccine was administered on 29-Jul-2022).    Concomitant medication was not reported.  It was reported that the patient was administered dose after 30 days use by date which was 2 days past expiry date.. The vial was kept in refrigerator on 27-Jun-2022 and the (BUD) refrigeration date was 27-Jul-2022. The size of the vial was 5.5 ml.   Treatment medication was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-681156 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-681156:same reporter case
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: Temp Excursion - Yes; Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022; No adverse event; Erroneously vaccinated clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 49-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 017B22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 29-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 27-Jun-2022 and was administered on 29-Jul-2022).    No concomitant medication was reported.  The date recd. was reported as 27-Jun-2022 and last date of vaccine administered was reported as 29-Jul-2022.  Before use date (refrigerator) was reported as 27-Jul-2022.  Patient received vaccine 2 days past expiry from vial of size 5.5 mL.  Vial had undergone the temperature excursion.  No treatment medication was reported.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022; No adverse event; erroneously vaccinated  clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 51-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine) and PRODUCT STORAGE ERROR (The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022).    Concomitant medications details were not reported by the reporter. It was reported that 10 days past expiry date the patient received the vaccine. Vial was initially stored in refrigerator on  07-JUN-2022. Vial size was reported as 5.5 ml. Vial did not undergo any temperature excursion. Treatment details were not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-681156 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-681156:Master case
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The (BUD) refrigeration date on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022; No adverse event; erroneously vaccinated clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated clients with expired vaccine), PRODUCT STORAGE ERROR (The (BUD) refrigeration date on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 40-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated clients with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The (BUD) refrigeration date on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated clients with expired vaccine), PRODUCT STORAGE ERROR (The (BUD) refrigeration date on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated clients with expired vaccine) and PRODUCT STORAGE ERROR (The (BUD) refrigeration date on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022).    Concomitant medications details were not reported by the reporter. It was reported that 10 days past expiry date the patient received the vaccine. Vial was initially stored in refrigerator on  07-JUN-2022. Vial size was reported as 5.5 ml. Vial did not undergo any temperature excursion. Treatment details were not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-681156.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-681156:Master Case
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: No adverse event; erroneously vaccinated  clients with expired vaccine; The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 29-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine) and PRODUCT STORAGE ERROR (The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine) and PRODUCT STORAGE ERROR (The (BUD) refrigeration date  on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022).    Concomitant medications details were not reported by the reporter.  It was reported that 10 days past expiry date the patient received the vaccine. Vial was initially stored in refrigerator on 07-JUN-2022. Vial size was reported as 5.5 ml. Vial did not undergo any temperature excursion.  Treatment details were not reported by the reporter.   This case was linked to MOD-2022-681156 (Linked Report).; Sender's Comments:  MOD-2022-681156:Master Case
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The (BUD) refrigeration date was on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022; No adverse event; Erroneously patient was vaccinated with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Erroneously patient was vaccinated with expired vaccine), PRODUCT STORAGE ERROR (The (BUD) refrigeration date was on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 37-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Erroneously patient was vaccinated with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The (BUD) refrigeration date was on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Erroneously patient was vaccinated with expired vaccine), PRODUCT STORAGE ERROR (The (BUD) refrigeration date was on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Erroneously patient was vaccinated with expired vaccine) and PRODUCT STORAGE ERROR (The (BUD) refrigeration date was on 01-Jul-2022 and vaccine was adminstered on 11-Jul-2022).    No concomitant medications were reported. Vial size was reported as 5.5 mL. Vial did not undergo any temperature excursion. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-681156 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-681156:MOD22-030180-Master Case,same reporter
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial was initially stored in the refrigerator on 07-Jun-2022 and was administered on 11-Jul-2022; No adverse event; erroneously vaccinated  clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 07-Jun-2022 and was administered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 52-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 11-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 07-Jun-2022 and was administered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 07-Jun-2022 and was administered on 11-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 07-Jun-2022 and was administered on 11-Jul-2022).    No concomitant medications were reported.  The Beyond use date (BUD) (refrigerator) was reported as 01-Jul-2022. It was reported that 10 days past expiry date the patient received the vaccine. Vial size was reported as 5.5 ml. Vial did not undergo any temperature excursion.   No treatment medications were reported.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Poor quality product administered, Product temperature excursion issue
Clinical narrative: Temp Excursion was Yes/ Received vaccine after beyond use date; No adverse event; Erroneously vaccinated  clients with expired vaccine/ Received vaccine that underwent temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine/ Received vaccine that underwent temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion was Yes/ Received vaccine after beyond use date) and NO ADVERSE EVENT (No adverse event) in a 56-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine/ Received vaccine that underwent temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion was Yes/ Received vaccine after beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine/ Received vaccine that underwent temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion was Yes/ Received vaccine after beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine/ Received vaccine that underwent temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion was Yes/ Received vaccine after beyond use date).    No concomitant medications were reported.  It was reported that the patient was administered a vaccine dose after 30 day use by which was 9 days past expiry date. The size of the vial was 2.5 ml. The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022. Beyond use date was reported as 02-Nov-2022. The vial had also undergone a temperature excursion.    No treatment information was reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: erroneously vaccinated with expired vaccine; The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.; vial undergo temperature excursions; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event) in a 71-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions).    No concomitant medications were reported. It was reported that the patient was administered dose after 30 day use by date.  The size of the vial was 2.5 ml.  Beyond use date was reported as 02-Nov-2022.  The vial underwent temperature excursion.  9 days past expiry date the patient received the vaccine. The last date the vaccine with lot number 057F22A was administered on 11-Nov-2022. No treatment information was reported.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: The vial was initially stored in the refrigerator on 03Oct2022, BUD was reported as 02Nov2022 and was administered on 11Nov2022; Temp Excursion - Yes; No adverse event; erroneously vaccinated clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated clients with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03Oct2022, BUD was reported as 02Nov2022 and was administered on 11Nov2022), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes) and NO ADVERSE EVENT (No adverse event) in a 52-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated clients with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03Oct2022, BUD was reported as 02Nov2022 and was administered on 11Nov2022), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated clients with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03Oct2022, BUD was reported as 02Nov2022 and was administered on 11Nov2022), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated clients with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03Oct2022, BUD was reported as 02Nov2022 and was administered on 11Nov2022) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes).    No concomitant medication were reported.  It was reported that the patient was administered dose after 30 day use by date. The size of the vial was 2.5 ml. The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022. Beyond use date was reported as 02-Nov-2022. The vial underwent temperature excursion. 9 days past expiry date the patient received the vaccine. No treatment information was provided by the reporter.   This case was linked to MOD-2022-681291 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: vial undergo temperature excursions; The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.; No adverse event; erroneously vaccinated  clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.).    No concomitant medication was provided.  It was reported that the patient was administered dose after 30 day use by date. The size of the vial was 2.5 ml. The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022. Beyond use date was reported as 02-Nov-2022. The vial underwent temperature excursion. 9 days past expiry date the patient received the vaccine.  Treatment medication was not provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-681321 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-681321:Same reporter
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: vial undergo temperature excursions; The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.; No adverse event; Erroneously vaccinated  clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and NO ADVERSE EVENT (No adverse event) in a 58-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.).    No concomitant medications were reported.  It was reported that the patient was administered dose after 30 day use by date. The size of the vial was 2.5 ml. The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022. Beyond use date was reported as 02-Nov-2022. The vial underwent temperature excursion. 9 days past expiry date the patient received the vaccine.   No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-681180 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-681180:MOD22-030180 Master Case
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: Temp Excursion - Yes; Temp Excursion - Yes; No adverse event; erroneously vaccinated  clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (Temp Excursion - Yes), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Temp Excursion - Yes), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (Temp Excursion - Yes), PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (Temp Excursion - Yes) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temp Excursion - Yes).    No concomitant medications were reported.  It was reported that the patient was administered dose after 30 day use by date. The size of the vial was 2.5 ml. The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022. Beyond use date was reported as 02-Nov-2022. The vial underwent temperature excursion. 9 days past expiry date the patient received the vaccine.   No treatment information was reported.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: Temp Excursion - Yes; The vial went to temperature excursion; No adverse event; erroneously vaccinated  clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (Temp Excursion - Yes), PRODUCT TEMPERATURE EXCURSION ISSUE (The vial went to temperature excursion) and NO ADVERSE EVENT (No adverse event) in a 68-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Temp Excursion - Yes), PRODUCT TEMPERATURE EXCURSION ISSUE (The vial went to temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (Temp Excursion - Yes), PRODUCT TEMPERATURE EXCURSION ISSUE (The vial went to temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (Temp Excursion - Yes) and PRODUCT TEMPERATURE EXCURSION ISSUE (The vial went to temperature excursion).    No concomitant medications were reported. It was reported that the patient was administered dose after 30 day use by date. The size of the vial was 2.5 ml. The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022. Beyond use date was reported as 02-Nov-2022. The vial underwent temperature excursion. 9 days past expiry date the patient received the vaccine.   No treatment information was reported.   Reporter did not allow further contact
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022.; vial undergo temperature excursions; No adverse event; erroneously vaccinated  clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022.), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022.), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022.), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated  clients with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022.) and PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions).    No concomitant medications were reported.  It was reported that the patient was administered dose after 30 day use by date. The size of the vial was 2.5 ml. The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022. Beyond use date was reported as 02-Nov-2022. The vial underwent temperature excursion. 9 days past expiry date the patient received the vaccine.   No treatment information was reported.   This case was linked to MOD-2022-514157 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error, Product temperature excursion issue
Clinical narrative: The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.; vial undergo temperature excursions; No adverse event; erroneously vaccinated with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (erroneously vaccinated with expired vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions).    No concomitant medications were reported.  It was reported that the patient was administered dose after 30 day use by date.   The size of the vial was 2.5 ml.   Beyond use date was reported as 02-Nov-2022.   The vial underwent temperature excursion.   9 days past expiry date the patient received the vaccine.  The last date the vaccine with lot number 057F22A was administered on 11-Nov-2022.  No treatment information was reported.   This case was linked to MOD-2022-514073 (Patient Link).
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Poor quality product administered, Product temperature excursion issue
Clinical narrative: Vial underwent temperature excursions/ Patient's received vaccine after BUD; No adverse event; Erroneously vaccinated  clients with expired vaccine/ Patient's received vaccine after BUD/ Vaccine underwent temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine/ Patient's received vaccine after BUD/ Vaccine underwent temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Vial underwent temperature excursions/ Patient's received vaccine after BUD) and NO ADVERSE EVENT (No adverse event) in a 60-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine/ Patient's received vaccine after BUD/ Vaccine underwent temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vial underwent temperature excursions/ Patient's received vaccine after BUD) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine/ Patient's received vaccine after BUD/ Vaccine underwent temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Vial underwent temperature excursions/ Patient's received vaccine after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine/ Patient's received vaccine after BUD/ Vaccine underwent temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vial underwent temperature excursions/ Patient's received vaccine after BUD).    No concomitant medications were reported.  It was reported that the patient was administered a vaccine dose after 30 day use by which was 9 days past expiry date. The size of the vial was 2.5 ml. The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022. Beyond use date was reported as 02-Nov-2022. The vial had also undergone a temperature excursion.    No treatment information was reported.   This case was linked to MOD-2022-513828 (Patient Link).